Abstract
Suicide gene therapy using viral transfer of herpes simplex virus type I (HSV-1) thymidine kinase (TK) and subsequent ganciclovir (GCV) chemotherapy was the first approach used in clinical trials of somatic gene therapy for glioblastoma. The molecular pathways mediating TK/GCV-induced cell death remain to be elucidated. Here, we report that adenoviral (Ad)-TK/GCV-induced death is p53-independent and does not involve altered CD95 or CD95L expression. Ectopic expression of the preferential caspase 8 inhibitor, crm-A, inhibits Ad-CD95L-induced cell death but has no effect on TK/GCV cytotoxicity. LN-18 glioma cells selected for resistance to death receptor-mediated cell death do not acquire cross-resistance to TK/GCV. TK/GCV triggers mitochondrial cytochrome c release and activation of caspases 3, 7, 8 and 9 in a death receptor-independent manner. These events are associated with the loss of BCL-X(L). Forced expression of a BCL-X(L) transgene, or co-exposure to a pseudosubstrate caspase inhibitor, zVAD-fmk, inhibit TK/GCV cytotoxicity. Double-transfected cell lines expressing crm-A and enhanced green fluorescent protein (eGFP) show that the bystander effect in vitro is also death receptor- and caspase 8-independent. TK/GCV therapy ...Continue Reading
References
Jun 12, 1992·Science·K W CulverR M Blaese
Jan 1, 1981·Advances in Cancer Research·M C Berenbaum
Sep 1, 1994·The Journal of Clinical Investigation·M WellerA Fontana
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·D BarbaF H Gage
Feb 1, 1997·The Journal of General Virology·A F SheringP R Lowenstein
Dec 13, 1997·Nature Medicine·Z RamE H Oldfield
Feb 24, 1998·British Journal of Cancer·W RothM Weller
Oct 6, 1998·Human Gene Therapy·C A MullenD Petropoulos
Dec 8, 1998·International Journal of Cancer. Journal International Du Cancer·M WellerJ Dichgans
Jan 29, 1999·The Journal of Cell Biology·E A SleeS J Martin
Mar 27, 1999·Human Gene Therapy·D CraperiJ M Verna
Apr 9, 1999·Cancer Gene Therapy·P X LiH J Klamut
Apr 16, 1999·Cell Death and Differentiation·B WagenknechtM Weller
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·C BeltingerK M Debatin
Jul 31, 1999·Human Gene Therapy·B B AmbarA Fontana
Aug 6, 1999·Gene Therapy·S J WeiW K Yang
Sep 22, 1999·Oncogene·T GlaserM Weller
Oct 9, 1999·Human Gene Therapy·N ShandN Barbier
Nov 5, 1999·Nature Medicine·R A DeweyP R Löwenstein
Nov 24, 1999·Human Gene Therapy·O WildnerJ C Morris
Dec 10, 1999·Experimental Cell Research·C BartussekM Weller
Citations
Jun 27, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marianela CandolfiMaria G Castro
Dec 25, 2010·Neuro-oncology·Günter EiseleMichael Weller
Jun 26, 2007·Biochemical and Biophysical Research Communications·Jufeng ZhangQian Huang
Jan 27, 2005·Biochemical and Biophysical Research Communications·Martin UhlUlrich Herrlinger
Mar 17, 2012·Toxicology Letters·Cuihong JinYuan Cai
Jul 6, 2010·Biochimica Et Biophysica Acta·Daniel Abate-DagaCristina Fillat
Apr 10, 2014·Journal of Traditional and Complementary Medicine·Liang-Tzung LinChun-Ching Lin
Dec 14, 2004·Oncogene·Ute FischerChristof M Kramm
Jun 28, 2005·Journal of Neuro-oncology·Chitra SarkarSubrata Sinha
Jul 10, 2020·Neuro-oncology Advances·Jubayer A HossainHrvoje Miletic
Jun 3, 2021·Nanomaterials·Vicente Candela-NogueraRamón Martínez-Máñez